Clinical Trial Detail

NCT ID NCT02954653
Title A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

acute myeloid leukemia

Therapies

PF-06747143

Cytarabine + Daunorubicin + PF-06747143

Azacitidine + Decitabine + PF-06747143

Age Groups: adult senior

No variant requirements are available.